RecruitingPhase 4NCT03718403
Effect of Theophylline in Pseudohypoparathyroidism
Studying Pseudohypoparathyroidism without Albright hereditary osteodystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Massachusetts General Hospital
- Principal Investigator
- AMITA SHARMA, MDMassachusetts General Hospital
- Intervention
- Theophylline(drug)
- Enrollment
- 100 enrolled
- Eligibility
- 5-21 years · All sexes
- Timeline
- 2019 – 2032
Study locations (1)
- Massachusetts General Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03718403 on ClinicalTrials.gov